Premium
Safety of measles immunization in egg‐allergic children
Author(s) -
Businco L.,
Grandolfo M.,
Bruno G.
Publication year - 1991
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/j.1399-3038.1991.tb00207.x
Subject(s) - medicine , measles , measles vaccine , vaccination , contraindication , egg allergy , immunization , population , allergy , immunology , limiting , incidence (geometry) , pediatrics , virology , environmental health , antibody , food allergy , mechanical engineering , physics , alternative medicine , optics , pathology , engineering
Measles vaccines are prepared in chick embryo fibroblast culture and used throughout the world. Since 1963 dramatic reductions in the incidence of measles have been observed where the vaccination was extensively applied in the pediatric population. The best results were observed when the target population in the initial phase was that which produced over 90% of cases in the pre‐vaccinal era. A possible limiting factor to the diffusion of measles vaccination is the assumption that allergy to egg proteins is a contraindication. In this paper current knowledge about the safety of measles immunization in children with egg allergy is discussed.